Ezra E. W. Cohen
AuthID: R-00G-DX4
1
TITLE: Pembrolizumab versus methotrexate, docetaxel, or cetuximab in recurrent or metastatic head and neck squamous cell carcinoma (KEYNOTE-040) : Subgroup analysis by pattern of disease recurrence Full Text
AUTHORS: Harrington, K. J.; Cohen, E. E. W.; Soulieres, D.; Dinis, J.; Licitra, L.; Ahn, M. j.; Soria, A.; Machiels, J. p.; Mach, N.; Mehra, R.; Burtness, B.; Swaby, R. F.; Lin, J.; Ge, J.; Lerman, N.; Le Tourneau, C.;
PUBLISHED: 2023, SOURCE: ORAL ONCOLOGY, VOLUME: 147
AUTHORS: Harrington, K. J.; Cohen, E. E. W.; Soulieres, D.; Dinis, J.; Licitra, L.; Ahn, M. j.; Soria, A.; Machiels, J. p.; Mach, N.; Mehra, R.; Burtness, B.; Swaby, R. F.; Lin, J.; Ge, J.; Lerman, N.; Le Tourneau, C.;
PUBLISHED: 2023, SOURCE: ORAL ONCOLOGY, VOLUME: 147
INDEXED IN: 
Scopus 
WOS
Scopus WOS2
TITLE: Pembrolizumab (pembro) vs standard-of-care (SOC) in previously treated recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): 6-year follow-up of KEYNOTE-040
AUTHORS: Soulieres, D.; Harrington, K. J.; Le Tourneau, C.; Silva, J. D.; Licitra, L. F.; Ahn, M J.; Soria, A.; Machiels, J P.; Mach, N.; Mehra, R.; Burtness, B.; Lin, J.; Lerman, N.; Gumuscu, B.; Cohen, E. E. W.;
PUBLISHED: 2022, SOURCE: Annual Meeting of the European-Society-for-Medical-Oncology (ESMO) in ANNALS OF ONCOLOGY, VOLUME: 33, ISSUE: 7
AUTHORS: Soulieres, D.; Harrington, K. J.; Le Tourneau, C.; Silva, J. D.; Licitra, L. F.; Ahn, M J.; Soria, A.; Machiels, J P.; Mach, N.; Mehra, R.; Burtness, B.; Lin, J.; Lerman, N.; Gumuscu, B.; Cohen, E. E. W.;
PUBLISHED: 2022, SOURCE: Annual Meeting of the European-Society-for-Medical-Oncology (ESMO) in ANNALS OF ONCOLOGY, VOLUME: 33, ISSUE: 7
INDEXED IN: WOS
WOS3
TITLE: Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040
AUTHORS: Harrington, KJ; Soulieres, D; Le Tourneau, C; Dinis, J; Licitra, LF; Ahn, MJ; Soria, A; Machiels, JPH; Mach, N; Mehra, R; Burtness, B; Ellison, MC; Cheng, JD; Chirovsky, DR; Swaby, RF; Cohen, EEW;
PUBLISHED: 2021, SOURCE: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, VOLUME: 113, ISSUE: 2
AUTHORS: Harrington, KJ; Soulieres, D; Le Tourneau, C; Dinis, J; Licitra, LF; Ahn, MJ; Soria, A; Machiels, JPH; Mach, N; Mehra, R; Burtness, B; Ellison, MC; Cheng, JD; Chirovsky, DR; Swaby, RF; Cohen, EEW;
PUBLISHED: 2021, SOURCE: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, VOLUME: 113, ISSUE: 2
INDEXED IN: Scopus WOS
Scopus WOS4
TITLE: Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial
AUTHORS: Burtness, B; Haddad, R; Dinis, J; Trigo, J; Yokota, T; De Souza Viana, L; Romanov, I; Vermorken, J; Bourhis, J; Tahara, M; Martins Segalla, JG; Psyrri, A; Vasilevskaya, I; Nangia, CS; Chaves Conde, M; Kiyota, N; Homma, A; Holeckova, P; Del Campo, JM; Asarawala, N; ...More
PUBLISHED: 2019, SOURCE: JAMA ONCOLOGY, VOLUME: 5, ISSUE: 8
AUTHORS: Burtness, B; Haddad, R; Dinis, J; Trigo, J; Yokota, T; De Souza Viana, L; Romanov, I; Vermorken, J; Bourhis, J; Tahara, M; Martins Segalla, JG; Psyrri, A; Vasilevskaya, I; Nangia, CS; Chaves Conde, M; Kiyota, N; Homma, A; Holeckova, P; Del Campo, JM; Asarawala, N; ...More
PUBLISHED: 2019, SOURCE: JAMA ONCOLOGY, VOLUME: 5, ISSUE: 8
INDEXED IN: Scopus WOS
Scopus WOS5
TITLE: Pembrolizumab (pembro) for recurrent head and neck squamous cell carcinoma (HNSCC): Post hoc analyses of phase 3 KEYNOTE-040 prior radiation treatment (RT) and disease state.
AUTHORS: Kevin J Harrington; Ezra E W Cohen; Denis Soulieres; Jose Dinis; Lisa F Licitra; Myung Ju Ahn; Ainara Soria; Jean Pascal H Machiels; Nicolas Mach; Ranee Mehra; Barbara Burtness; Jianxin X Lin; Jonathan D Cheng; Ramona F Swaby; Christophe Le Tourneau;
PUBLISHED: 2019, SOURCE: Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 37, ISSUE: 15
AUTHORS: Kevin J Harrington; Ezra E W Cohen; Denis Soulieres; Jose Dinis; Lisa F Licitra; Myung Ju Ahn; Ainara Soria; Jean Pascal H Machiels; Nicolas Mach; Ranee Mehra; Barbara Burtness; Jianxin X Lin; Jonathan D Cheng; Ramona F Swaby; Christophe Le Tourneau;
PUBLISHED: 2019, SOURCE: Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 37, ISSUE: 15
INDEXED IN: WOS
WOS6
TITLE: Pembrolizumab for recurrent head and neck squamous cell carcinoma (HNSCC): Post hoc analyses of treatment options from the phase III KEYNOTE-040 trial
AUTHORS: Le Tourneau, C; Cohen, EEW; Harrington, KJ; Dinis, J; Licitra, L; Ahn, MJ; Soria, A; Machiels, JP; Mach, N; Mehra, R; Burtness, B; Zhang, P; Cheng, J; Swaby, R; Soulieres, D;
PUBLISHED: 2018, SOURCE: 43rd ESMO Congress (ESMO) in ANNALS OF ONCOLOGY, VOLUME: 29
AUTHORS: Le Tourneau, C; Cohen, EEW; Harrington, KJ; Dinis, J; Licitra, L; Ahn, MJ; Soria, A; Machiels, JP; Mach, N; Mehra, R; Burtness, B; Zhang, P; Cheng, J; Swaby, R; Soulieres, D;
PUBLISHED: 2018, SOURCE: 43rd ESMO Congress (ESMO) in ANNALS OF ONCOLOGY, VOLUME: 29
INDEXED IN: WOS
WOS7
TITLE: Updated survival results of the KEYNOTE-040 study of pembrolizumab vs standard-of-care chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma
AUTHORS: Denis Soulieres; Ezra Cohen; Christophe Le Tourneau; Jose Dinis; Lisa Licitra; Myung Ju Ahn; Ainara Soria; Jean Pascal Machiels; Nicolas Mach; Ranee Mehra; Barbara Burtness; Pingye Y Zhang; Jonathan Cheng; Ramona Swaby; Kevin J Harrington;
PUBLISHED: 2018, SOURCE: Annual Meeting of the American-Association-for-Cancer-Research (AACR) in CANCER RESEARCH, VOLUME: 78, ISSUE: 13
AUTHORS: Denis Soulieres; Ezra Cohen; Christophe Le Tourneau; Jose Dinis; Lisa Licitra; Myung Ju Ahn; Ainara Soria; Jean Pascal Machiels; Nicolas Mach; Ranee Mehra; Barbara Burtness; Pingye Y Zhang; Jonathan Cheng; Ramona Swaby; Kevin J Harrington;
PUBLISHED: 2018, SOURCE: Annual Meeting of the American-Association-for-Cancer-Research (AACR) in CANCER RESEARCH, VOLUME: 78, ISSUE: 13
INDEXED IN: WOS
WOS8
TITLE: Pembrolizumab for recurrent head and neck squamous cell carcinoma (HNSCC): Post hoc analyses of treatment options from the phase III KEYNOTE-040 trial
AUTHORS: Le Tourneau, C; Cohen, EEW; Harrington, KJ; Dinis, J; Licitra, L; Ahn, MJ; Soria, A; Machiels, JP; Mach, N; Mehra, R; Burtness, B; Zhang, P; Cheng, J; Swaby, R; Soulières, D;
PUBLISHED: 2018, SOURCE: Annals of oncology : official journal of the European Society for Medical Oncology, VOLUME: 29
AUTHORS: Le Tourneau, C; Cohen, EEW; Harrington, KJ; Dinis, J; Licitra, L; Ahn, MJ; Soria, A; Machiels, JP; Mach, N; Mehra, R; Burtness, B; Zhang, P; Cheng, J; Swaby, R; Soulières, D;
PUBLISHED: 2018, SOURCE: Annals of oncology : official journal of the European Society for Medical Oncology, VOLUME: 29
INDEXED IN: Scopus
Scopus9
TITLE: Pembrolizumab (pembro) vs standard of care (SOC) for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): Phase 3 KEYNOTE-040 trial
AUTHORS: Cohen, EE; Harrington, KJ; Le Tourneau, C; Dinis, J; Licitra, L; Ahn, MJ; Soria, A; Machiels, JP; Mach, N; Mehra, R; Burtness, B; Wang, Y; Tuozzo, AJ; Swaby, R; Soulieres, D;
PUBLISHED: 2017, SOURCE: 42nd European-Society-for-Medical-Oncology Congress (ESMO) in ANNALS OF ONCOLOGY, VOLUME: 28
AUTHORS: Cohen, EE; Harrington, KJ; Le Tourneau, C; Dinis, J; Licitra, L; Ahn, MJ; Soria, A; Machiels, JP; Mach, N; Mehra, R; Burtness, B; Wang, Y; Tuozzo, AJ; Swaby, R; Soulieres, D;
PUBLISHED: 2017, SOURCE: 42nd European-Society-for-Medical-Oncology Congress (ESMO) in ANNALS OF ONCOLOGY, VOLUME: 28
INDEXED IN: WOS
WOS10
TITLE: An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck Full Text
AUTHORS: Vassiliki Saloura; Ezra E W Cohen; Lisa Licitra; Salem Billan; Jose Dinis; Steen Lisby; Thomas C Gauler;
PUBLISHED: 2014, SOURCE: CANCER CHEMOTHERAPY AND PHARMACOLOGY, VOLUME: 73, ISSUE: 6
AUTHORS: Vassiliki Saloura; Ezra E W Cohen; Lisa Licitra; Salem Billan; Jose Dinis; Steen Lisby; Thomas C Gauler;
PUBLISHED: 2014, SOURCE: CANCER CHEMOTHERAPY AND PHARMACOLOGY, VOLUME: 73, ISSUE: 6
